CVA Family Office’s Repligen RGEN Stock Holding History

CVA Family Office’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91K	Buy	+14	New	+$1.72K	﹤0.01%	1526
2025 Q3	–	Sell	-4	Closed	-$498	–	1337
2025 Q2	$498	Sell	4 -3	-43%	-$382	﹤0.01%	1236
2025 Q1	$891	Buy	7 +3	+75%	+$462	﹤0.01%	1135
2024 Q4	$576	Hold	4	–	–	﹤0.01%	1192
2024 Q3	$595	Buy	+4	New	+$574	﹤0.01%	1162
2022 Q2	–	Sell	-60	Closed	-$11K	–	978
2022 Q1	$11K	Hold	60	–	–	﹤0.01%	665
2021 Q4	$16K	Buy	+60	New	+$16.2K	﹤0.01%	563
2021 Q3	–	Sell	-75	Closed	-$15K	–	771
2021 Q2	$15K	Buy	+75	New	+$14.5K	﹤0.01%	585

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CVA Family Office's RGEN Position: Q2 2026 in Review

CVA Family Office opened a new position in Repligen (RGEN) in Q2 2026: 14 shares worth $1.91K. The stake represents ﹤0.01% of the portfolio and ranks #1526 among its holdings. This is a return to the name: CVA Family Office previously reported a position in RGEN as recently as Q2 2025.

CVA Family Office first reported a position in RGEN in Q2 2021 and has held it in 8 quarters since. The position peaked at $16K in Q4 2021. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

CVA Family Office held 14 shares of Repligen worth $1.91K as of Q2 2026.
Repligen was a new CVA Family Office position in Q2 2026.
Repligen made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1526 holding.
CVA Family Office first reported a position in Repligen in Q2 2021 and has held it in 8 quarters since.
CVA Family Office's Repligen position peaked at $16K in Q4 2021.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.